Skip to content
Lower risk Medical device recall · FDA · Published March 24, 2021

Becton Dickinson BioGX SARS-CoV-2 Reagents for BD MAX System: Unsealed Tubes Risk False

Becton Dickinson recalls BioGX SARS-CoV-2 Reagents for BD MAX System PCR tests due to unsealed rehydration buffer tubes that may cause false negative results. Affected lots listed in the recall.

🇺🇸 FDA recall #Z-1416-2021Medical deviceBecton Dickinson ›
Take action

Contact the company

Recalling firmBecton Dickinson & Co.7 Loveton Cir · Sparks, MD 21152-9212
✎ GovInfoNow plain-language explainer

Becton Dickinson is recalling BioGX SARS-CoV-2 Reagents for BD MAX System PCR tests because some rehydration buffer tubes weren't sealed properly. This could lead to false negative results on the test, meaning the test might show no infection when there is one. Read more at govinfonow.com/recall/62989-becton-dickinson-biogx-sars-cov-2-reagents-for-bd-max.

Source Summary by GovInfoNow · govinfonow.com/recall/62989-becton-dickinson-biogx-sars-cov-2-reagents-for-bd-max · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1416-2021

Cite this page

“Becton Dickinson BioGX SARS-CoV-2 Reagents for BD MAX System: Unsealed Tubes Risk False.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/62989-becton-dickinson-biogx-sars-cov-2-reagents-for-bd-max. Based on FDA recall #Z-1416-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1416-2021%22&limit=1).

The FDA announced on March 24, 2021, that Becton Dickinson & Co. is recalling BioGX SARS-CoV-2 Reagents for the BD MAX System due to sealing defects in rehydration buffer tubes. The agency said the defect may cause unresolved test results. Owners should contact the company for a remedy.

How to tell if you have it

  • Brand: Becton Dickinson
  • Product: BioGX SARS-CoV-2 Reagents for BD MAX System
  • Catalog Number: 444213
  • Lot Numbers: K20-347 through K20-643 (see record for full list)
  • Expiration Dates: 1/23/2021 through 5/17/2021
  • UDI: 382904442132
  • Units affected: 21,529 Kits
  • Distribution: US Nationwide

The hazard

The rehydration buffer tubes were not adequately sealed, causing some to be partially filled or empty upon use. A partially filled or empty tube may lead to an Unresolved (UNR) result on the BD MAX System.

Context

GovInfoNow's records show Becton Dickinson & Co. has 43 other recalls on record since June 1, 2017. Other recent recalls of similar products include the BD GasP: CO2 Pouch System Recall (April 7, 2026), the BD Kiestra Isolate Suspension Cuvette Array recall (Oct. 23, 2025), and the Becton Dickinson & Co. Product Catalog recall (Sept. 23, 2025). Other recent recalls of similar products include the Biomerieux VITEK 2 AST-N447 Kit Recall (June 4, 2026), the Biomerieux VITEK 2 AST-N461 Test Kit Recall (July 24, 2026), and the Medline Blood Culture Kit Recall (Dec. 24, 2025).

How to tell if you have this one

Check the lot numbers and expiration dates listed in the recall: K20-347 through K20-639 with expiration dates from January 23, 2021 to May 13, 2021. The product is for PCR testing of SARS-CoV-2 in nasopharyngeal specimens.

  • Brand
    Becton Dickinson
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Review the lot number and expiration date on the reagent packaging to confirm if it's in the affected list.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “US Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 16 months after the firm started it.

1. Firm started the recall: Mar 24, 202112. FDA classified it Class II: Apr 12, 202123. Published in FDA’s Enforcement Report: Apr 21, 202134. FDA terminated the recall: Aug 2, 2022420212022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1416-2021 (March 24, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1416-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA